These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3859930

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N, Shuster JJ, Bowman WP, Borowitz M, Farrow A, Jacaruso D, Buchanan GR, Kamen BA.
    J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
    [Abstract] [Full Text] [Related]

  • 24. High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience.
    Harris RE, Sather HN, Feig SA.
    Med Pediatr Oncol; 1998 Apr; 30(4):233-9. PubMed ID: 9473758
    [Abstract] [Full Text] [Related]

  • 25. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N, Traggis D, Das L, Kim BS, Won H, Hann L, Moloney WC, Dohlwitz A.
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract] [Full Text] [Related]

  • 26. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
    Castel V, Verdeguer A, Ferris J, Esquembre C.
    An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
    [Abstract] [Full Text] [Related]

  • 27. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
    Smithson WA, Gilchrist GS, Burgert EO.
    Med Pediatr Oncol; 1979 Nov; 6(2):163-70. PubMed ID: 287856
    [Abstract] [Full Text] [Related]

  • 28. Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia.
    Capizzi RL, Cheng YC.
    Med Pediatr Oncol; 1982 Nov; 10 Suppl 1():221-8. PubMed ID: 6962320
    [Abstract] [Full Text] [Related]

  • 29. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA, Makhonova LA.
    Vestn Akad Med Nauk SSSR; 1986 Nov; (5):15-7. PubMed ID: 3487897
    [No Abstract] [Full Text] [Related]

  • 30. Leukemia relapse in long-term survivors of acute leukemia.
    Kawashima K, Nagura E, Yamada K, Hamajima N.
    Cancer; 1985 Jul 01; 56(1):88-94. PubMed ID: 3859360
    [Abstract] [Full Text] [Related]

  • 31. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
    Kamen BA, Casper J, Lauer S, Camitta BM, Holcenberg JS.
    Cancer Treat Rep; 1986 Jul 01; 70(7):935-6. PubMed ID: 3459577
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of prednisolone and vincristine with and without L-asparaginase in acute lymphatic leukemia of childhood.
    Choudhry VP, Marwaha RK, Goyal DP, Sarya AK.
    Indian J Pediatr; 1983 Jul 01; 50(407):619-22. PubMed ID: 6594318
    [No Abstract] [Full Text] [Related]

  • 33. Experiences with cytosine arabinoside in childhood leukaemia and lymphoma.
    Lay HN, Colebatch JH, Ekert H.
    Med J Aust; 1971 Jul 24; 2(4):187-92. PubMed ID: 5285817
    [No Abstract] [Full Text] [Related]

  • 34. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
    Marín P, Grañena A, Carreras E, Sierra J, Olivé MT, Rozman C.
    Sangre (Barc); 1984 Jul 24; 29(4-A):399-404. PubMed ID: 6594782
    [No Abstract] [Full Text] [Related]

  • 35. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
    Inagaki C, Ito K, Omori I, Shimazaki C, Nishio A, Haruyama H, Isemura T, Nakagawa M, Ijichi H.
    Gan To Kagaku Ryoho; 1985 Feb 24; 12(2):379-82. PubMed ID: 3855616
    [Abstract] [Full Text] [Related]

  • 36. The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL.
    Med Pediatr Oncol; 1982 Feb 24; 10(5):501-10. PubMed ID: 6755207
    [Abstract] [Full Text] [Related]

  • 37. Combination chemotherapy of carboplatin and cytosine arabinoside for high-risk leukemia: a pilot study.
    Iwao N, Yoshida M, Hatake K, Hoshino Y, Hagiwara S, Tomizuka H, Shimizu R, Suzuki T, Furukawa Y, Komatsu N.
    Leuk Res; 1995 Dec 24; 19(12):899-903. PubMed ID: 8632658
    [Abstract] [Full Text] [Related]

  • 38. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
    Rivera G, Murphy SB, Aur RJ, Verzosa MS, Dahl GV, Mauer AM.
    Cancer; 1978 Dec 24; 42(6):2521-8. PubMed ID: 282003
    [No Abstract] [Full Text] [Related]

  • 39. [Sequential high-dose cytarabine therapy in combination with asparaginase in acute myeloid leukemia].
    Radtke H, Pees HW, Schwamborn J, Thumser B, Daus H.
    Onkologie; 1988 Dec 24; 11(6):276-81. PubMed ID: 3071762
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.